“Working with the DMD Hub team was instrumental in the fast identification of potential new study sites for the SIDEROS study in the UK, enabling us to expand the patient enrolment possibilities. The team has also been highly supportive in identifying potential barriers to patient enrolment and has worked with us to help to overcome these challenges. This should ensure that patients with DMD continue to have the widest possible access to the Santhera clinical trial”

Catherine Lawrence

Santhera (UK) Ltd
Medical Advisor UK & Ireland